renee-tocco-123x163
Renee Tocco Hunter, DC – Director

Chiropractic Physician, HFA Doctor, Founder of Heart For Autism

Dr. Tocco Hunter was trained by top clinical researchers at the Autism Research Institute’s “Defeat Autism Now!” conference. She then furthered her studies under Dr. William Shaw of The Great Plains Laboratory, Inc. In 2008, she founded the American Chiropractic Autism Board and is the curriculum coordinator for Hope For Autism (HFA), a BioNutritional Care training conference. She received her doctorate of chiropractic degree from Sherman College of Straight Chiropractic.
read more

As the daughter of a successful doctor, Sam Tocco, D.C. of Michigan, Dr. Tocco Hunter grew up witnessing the miracles of living with a vitalistic philosophy. Her mother, Mary Tocco, encouraged her to pursue care for autism as Mary has been intricately connected to the autism community for years. She is a national public speaker, consultant and trainer on methods to help children and adults with various conditions and diseases. Her focus is on healthcare issues common among those who suffer from autism spectrum disorder. She promotes a vitalistic healthcare approach and is dedicated to educating the public about non-invasive, natural healthcare.
MarcGirard-123x163
Marc Girard MD, Msc

Medical Doctor

After a first training leading to a MSc in mathematics (partial differential equations), Marc Girard became a MD in parallel of his research on mathematical modelling. He works on drugs mainly as a consultant for pharmaceutical firms, and also practices as a psychotherapist of Freudian obedience. Besides a number of scientific papers, he published also in literary criticism, esp. about Flaubert, Balzac, Zola as well as the Grimm’s tales.
read more

His experience as a drug specialist goes from the early phases of development (I, II and III) to late post-marketing, with a long standing interest in safety (monitoring of clinical trials, pharmacovigilance, pharmacoepidemiology): as early as in 1984, he was the first French author to publish a criticism on the methods used to assess the causality of drugs adverse reactions. He also has a long practice of co-operation with regulatory departments as well as marketing teams, including the redaction of a number of experts reports and medical writing (papers, brochures, proceedings). Before of being struck off the list of medical expert witnesses (mainly for having written scientific papers calling for a reappraisal of the benefit/risk ratio hepatitis B vaccination), he was commissioned by French Judges in a number of judicial litigations involving drugs (growth hormone, appetite suppressants, cerivastatine, vaccines…); in France, his papers published in judicial journals (about drug causality or defective products) have been appreciated by a number of lawyers and magistrates.
Boyd.Haley-123x163
Boyd Haley, PhDEmeritus

Professor of Chemistry/Biochemistry in the Department of Chemistry -University of Kentucky Markey Cancer Center

Dr. Haley received his BS in Chemistry/Physics from Franklin College in 1963. From 1964 to 66 he served as a medic in the U.S. Army. He obtained his M.S. in Chemistry at the University of Idaho (1967) and his Ph.D. in Chemistry/Biochemistry at Washington State University (1971). He was an NIH Postdoctoral Scholar in the Department of Physiology, Yale University Medical School from 1971 to 1974. His first academic appointment was at the University of Wyoming in 1974 where he was promoted to full professor in 1983.
read more

In 1985 he was hired by the University of Kentucky Markey Cancer Center with academic appointments as professor in the College of Pharmacy and in the Department of Biochemistry. He is currently Emeritus Professor of Chemistry/Biochemistry in the Department of Chemistry and served as Chair of this department from 1996 to 2005. He was a founder and is the scientific advisor of ALT Biosciences, Inc., a biotech company that synthesizes and markets to major research institutes nucleotide photoaffinity analogs for biomedical research. In the past 23 years Dr. Haley has emphasized studies on the biochemistry of Alzheimer’s disease. [wpex more=”Read more” less=”Read less”]His research in the biochemical aberrancies in Alzheimer’s disease also lead to his identifying mercury toxicity as a major exacerbating factor, perhaps even a causal factor for this disease. He was one of the first to propose that the organic-mercury preservative (thimerosal) in vaccines was the most likely toxic agent involved in Gulf War Syndrome and autism related disorders. He has followed this up with research that demonstrates that several additional factors (Al3+, certain antibiotics), including testosterone, increase the toxicity of thimerosal. Further, in collaboration with others he has shown using mercury analysis of birth-hair that autistics represent a subset of the population that cannot excrete mercury effectively.

In the past few years Dr. Haley has testified before numerous government agencies at the federal and state levels on the effects of mercury toxicity from dental amalgams and vaccines. This list includes two times before the Congressional Committee on Government Reform, the Pentagon to Surgeon Generals, the Institute of Medicine of the National Academy of Sciences. He has testified before, and supplied affidavits to, numerous legislative committees at the State level that were considering bills to remove thimerosal and mercury from dental and vaccines products. In several situations states have enacted legislation placing restrictions on the use of mercury in dental and vaccine products. In the recent past he has testified before the FDA committee for Review and Analysis of the Literature on the Health Effects of Dental Amalgams and before the Institute of Medicine of the National Academy of Sciences regarding vaccines and autism.

Dr. Haley has been invited to present lectures on the subject of mercury toxicity and neurological diseases at international conferences in England, Scotland, Canada, Italy, Switzerland, Australia, Sweden, France, Germany, New Zealand, Mexico and Denmark.

Boyd.Haley-123x163
Dr. Philip Incao

One of the first practitioners of Anthroposophic Medicine in the U.S. He had a busy family practice in upstate New York in a Waldorf school-and biodynamic farming community for 23 years, until 1996. He then moved to Denver to help the growth of anthroposophic medicine in the west. He founded and practiced at the Gilpin Street Holistic Center in Denver until August 2006, when he moved to Crestone, Colorado where he continues to practice part-time in his home. Crestone is four hours south of Denver by car, and is about the same distance from Santa Fe, New Mexico.read more

Dr. Incao’s special interest is learning how to apply to practical healing Rudolf Steiner’s invaluable and profound insights into the human being.Dr. Incao has been studying children’s health, the immune system, infections and vaccinations since 1970, and has given many lectures and written several articles on these topics.Dr. Incao wrote two chapters and the concluding summary of the book, The Vaccination Dilemma, edited by Christine Murphy and published by Steiner Books. Dr Incao’s article on vaccinations and the immune system, “Supporting Children’s Health” in the September 1997 issue of Alternative Medicine Digest magazine, generated much interest and was reprinted in Asia, Norway, Canada and Australia. He has served as an expert witness in court of law in several trials concerning vaccinations and has submitted medical opinions in support of parents seeking compensation for their vaccine-damaged children.Philip Incao studied liberal arts and life sciences at Wesleyan University and then received his MD from Albert Einstein College of Medicine in 1966. He studied Anthroposophy and Anthroposophic Medicine in Forest Row, England and Arlesheim, Switzerland.
andrea.maniotis-123x163
Andrew Maniotis MD

Program Director in the Cell and Developmental Biology of Cancer Departments of Pathology, and Bioengineering, University of Illinois at Chicago

Dr. Andrew Maniotis is Program Director in the Cell and Developmental Biology of Cancer, Department of Pathology, Anatomy and Cell Biology, and Bioengineering in the College of Medicine Research Building at the University of Illinois at Chicago.
View Education

Pre-Graduate Education and Research:
1980-1983. A. B., Physical anthropology. Laboratory focus: human osteology.

Professors Stephen Molnar, Robert Sussman, directors.

Department of Anthropology, Washington University, St. Louis, MO.

1983-1985. Research Technician, Laboratory focus: neuroexitotoxicity, and developmental neurobiolgy. Dr.John Olney, and Dr. Richard Bunge, directors. McDonnell Center For Higher Brain Function, Departments of Psychiatry, Anatomy Cell Biology, Washington University School of Medicine, St. Louis, MO.

1985-1986. Research Technician, Laboratory focus: muscle development. Professor Richard Strohman, director. Department of Zoology, University of California , Berkeley CA .
Graduate Education and Postgraduate Research:

1986-1991. Ph.D., Cell biology, Laboratory of cytoskeletal biology. Professor Manfred Schliwa, director and graduate advisor. Departments of Zoology, Cell and Molecular Biology, University of California , Berkeley , CA .

1991-1992. NIH-Post-Doctoral Fellow in Cell Biology, Cell Biology Group,

Dr. Thoru Pederson, director. Worcester Foundation For Experimental Biology, Shrewsbury , MA .

1992-1997. Fellow in Surgical Research, Laboratory of tumor angiogenesis,

Dr. Donald Ingber, Post-Doctoral Advisor, Dr. Judah Folkman, director.

Department of Surgical Research and Pathology, Harvard Medical School , Boston MA .

1997-2000. Research Scientist, Department of Anatomy and Cell Biology, and the

Iowa Cancer Center, Mary Hendrix, director, University of Iowa, Iowa City, IA.

2000-2007. Assistant Professor of Pathology, Anatomy and Cell Biology, and Adjunct Prof. of Bioengineering. Program director of The Cell and Developmental Biology of Cancer, University of Illinois , Chicago , Chicago IL . 60612.

View Honors & Awards
Honors, lectures, awards:

1988. Stipend For Evolutionary studies, Museum of Vertebrate Zoology, University of California, Berkeley CA. 1990.

1992. USDA Fellowship in the Molecular Biology of Insect Viruses, Department of Entomological Sciences, University of California, Berkeley, CA.

1994. Zum Thema Wissensbank Honorarium.

1995. Invited speaker, Gordon Confererence on “The Biological Basis of Cell and Tissue Structure and Function”, Copper Mountain, CO.

1997. Work presented by “The Second Annual Videoconference On Space Station Research”, NASA.

1997. Work presented by The Faraday Society.

1998. Work presented by “The Penrose-Hameroff Colloquium.”

1998. Work cited by The Royal Society, London.

1999. Invited Lectureship:Biological Physics Colloquium, Banff, Canada.

2000. Research Colloquium Lectureship on Integrins, Madison, WI.

2000. Earnest Orlando Lawrence Berkeley National Laboratory Lectureship, Berkeley, CA.

2001 . Physicochemical processes in biological systems in space overstudy panel report.

2002. Nomination for Bodossaki Foundation Award, Athens, Greece.

2003. Who’s who in American Science; 2003-2005.

2003. Invited Speaker: Gordon Conference on Polyamines, New London, CT.

2003. Invited Speaker: FASEB conference Chromatin Structure and Cancer, Saxon Rivers, VT.

2005. Lectureship Colloquium on Polyamines, Cellgate, Pharmaceuticals, Redwood City, CA.

2005. First and second place winner, Health and Medicine Engineering, UIC., Chicago , IL .

2006. TREC Accelerator Award Recipient on Viral Assays, National Center For Supercomputing Applications, Champaign-Urbana, IL. http://www.trecc.org/accelerator/awardees.htm

Additional Activities
Other Activities: Invited Member of The Boston Vascular Task Force, Children’s hospital, Boston MA . 1995-1997, Judah Folkman, director.

Study section(s): Ad Hoc Grant Reviewer: “Therapeutic Modulation of Angiogenesis in Disease.” NCI, 1998-9. Invited member: “APA, Screening Technologies Branch DTP, DCTD, NCI.” Fall 2000.

Reviewer: American Journal of Physiology, Journal of Cellular Biochemistry, Investigative Ophthalmology and Visual Science, FACEB Journal, American Journal of Pathology, PNAS, British Medical Journal, Medical Veritas, and others.

Reseach Programs and Goals: Cancer therapeutics through microenvironment manipulation; vaccine adjuvants and cancer; tensegrity modeling; biochemical reconstruction of chromosomes; viral assay development; mechanogenomics, biofilm biology, oncolytic therapy of cancer, genome evolution, immune suppression and cancer.

Publications
Publications:

1)—Clifford, DB.,Olney, J.W.,Maniotis, A.,Collins, RC., Zorumski, CF. The functional anatomy and pathology of Lithium-Pilocarpine and high dose pilocarpine seizures. Neuroscience Vol 23 (3): pp.953-968, 1987.

2)—Strohman, R.C., Bayne, E., Spector,D., Obinata,T., Micou-Eastwood, J., Maniotis A. Myogenesis and histogenesis of skeletal muscle on flexible membranes. In Vitro Cell Dev. Biology, Vol 26: pp. 201-208, 1990.

3)—Maniotis, A., Schliwa, M. Microsurgical removal of centrosomes blocks cellular reproduction and centrosome regeneration in BSC-1 cells. Cell, Vol. 67 pp.201-208, 1991.

4)—Schutze, K., Maniotis, A., Schliwa, M. The position of the microtubule-organizing center in directionally migrating fibroblasts depends on the nature of the substratum. Proc. Nat. Acad. Sci. Vol. 88 pp. 8367-8371, 1991.

5)—Ingber,D. Dike, L., Hansen, L., Karp, S., Liley, H., Maniotis, A., McNamee, H., Mooney, D., Sims, J., Wang, N. Cellular tensegrity: exploring how mechanical changes in the cytoskeleton regulate cell growth, migration, and tissue pattern during morphogenesis. Int Rev Cytol. 150:173-224,1994.

6)—Maniotis, A., Chen, C., Ingber, D. Demonstration of mechanical interconnections between integrins, cytoskeletal filaments, and nuclear scaffolds that stabilize nuclear structure. Proc. Nat. Acad. Sci . Vol. 94 pp.849-854, 1997.

7)—Maniotis, A., Bojanowski, K., Ingber, D. Mechanical continuity and reversible chromosome disassembly within intact genomes removed from living cells. J. Cellular Biochem. Vol 65: 114-130, 1997.

8)—Bojanowski, K., Maniotis, A., Ingber, D. DNA toposiomerase ll can control chromatin topology and drive chromosome condensation without enzymatically modifying DNA. J. Cellular Biochem. Vol. 69:127-142,1998.

9)—Eckes, B., Dogic, D., Colucci-Guyon, E., Wang, N, Maniotis, A., Ingber, D., Merckling, A., Aumailley, M., Delouvee, M., Koteliansky, V., Babinet, C., Krieg, T. Impaired mechanical stability, migration, and contractile capacity in vimentin-deficient fibroblasts. J. Cell Science Vol. 111: 1897-1907, 1998.

10)—Eckes, B.; Martin, P.; Smola, H.; Dogic, D.; Colucci-Guyon, E.; Maniotis, A.;Wang, N.; Aumailley, M.; Ingber, D.; Babinet, C.; Krieg, T Disruption of tensegrity in vimentin-deficient fibroblasts causes delayed wound healing in fetal and adult mice. J. of Dermatol. Sci. Vol: 16, Issue: 1001, pp. 120., 1998.

11)—Pourati J, Maniotis A, Spiegel D, Schaffer JL, Butler JP, Fredberg JJ, Ingber DE, Stamenovic D, Wang N. Is cytoskeletal tension a major determinant of cell deformability in adherent endothelial cells? Am. J. Physiol. May; 274 ( 5 Pt 1):C1283-C1289, 1998.

12)—Chen, C. Ingber, D, and Maniotis A. A Strategy for Research in Space Biology and Medicine In the New Century. Physiology, Gravity, Space, Chapter 6, 1998.

13)—Goldman, WF.,Alonso JL, Bojanowski, K.,Bragwynne, C., Chen C.S., Chirchurel, M.E., Dike, L.,Huang, S., Lee, K-M., Maniotis, A., Mannix, R.,McNamee, H.,Meyer, C., Naruse, K, Parker, K.K., Plopper, G., Polte, T., Wang, N., Yan, L., Ingber, D.E. Cell shape Control and Mechanical Signaling Through the Cytoskeleton. The Cytoskeleton and Signaling: A Practical Approach. Chapter 11, 1999.

14)—Maniotis A., Folberg R., Hess A., Seftor E., Gardner L., Pe’er J., Trent J., Meltzer P., Hendrix M. Vascular channel formation by human uveal melanoma cells in vivo and in vitro: Vasculogenic mimicry. Amer. J. Path. Vol. I55, No 3, pps. 739-752, September, 1999.

15)—Katherine Verdolini, Steven Zeitels, Andrew Maniotis, Rosemary Desloge, Robert Hillman. Role of Mechanical Stress in Tissue Recovery Subsequent to Acute Phonotrauma. Speech-Language. Path., June, 1999.

16)—Robert Folberg, Mary Hendrix, and Andrew Maniotis. Vasculogenic Mimicry and Tumor Angiogenesis. American Journal of Pathology, Vol 156, No.2, 2000.

17)—Michael A. Warso, Andrew Maniotis, Xue Chen, Dibyen Majumdar, Niu K. Patel, Anne Shilkaitis, tapas K. Das Gupta, Robert Folberg. Prognostic Significance of Vasculogenic mimicry patterns in primary cutaneous melanoma. Clin Cancer Res. Mar;7(3):473-7, 2001.

18)—Folberg R, Chen X, Boldt HC, Pe’er J, Brown CK, Woolson RF, Maniotis AJ: Microcirculation patterns other than loops and networks in choroidal and ciliary body melanomas. Ophthalmology, 98:996-1001, 2001.

19)—Andrew Maniotis, Xue Chen, Christopher Garcia, Phillip J. DeChristopher, Ding Wu, Jacob Pe’er, Robert Folberg. Control of Melanoma Morphogenesis Endothelial Survival, and Perfusion By Extracellular Matrix. Lab Investigation. Vol. 82 No. 8 p.1083-1092, 2002.

20)—A. Mueller, A. Maniotis, W. Freeman, D. Bartch, U.Schaller, G.Bergeron-Lynn, L. Cheng, Taskintuna, X. Chen, J. Kan-Mitchell, R. Folberg. An orthotopic model for human uveal melanoma in SCID mice. Microvasc Res Vol. 44, 2002.

21)—Chen X, Maniotis AJ, Majumdar D, Pe’er J, Folberg R: Uveal melanoma cell staining for CD34 and the assessment of tumor vascularity. Invest Ophthalmol Vis Sci. Aug; 43(8): 2533-9, 2002.

22)—Seftor EA, Meltzer PS, Kirschmann DA, Pe’er J, Maniotis AJ, Trent JM, Folberg R, Hendrix MJ. Molecular determinants of human uveal melanoma invasion and metastasis. Clin Exp Metastasis, 19(3) 233-46, 2002.

23)—Chen X, Ai Z, Rasmussen M, Bajcsy P, Auvil L, Welge M, Leach L, Vangveeravong S, Maniotis AJ, Folberg R. Three-dimensional reconstruction of extravascular matrix patterns and blood vessels in human uveal melanoma tissue: techniques and preliminary findings. Investigative Ophthalmology and Visual Science. 44:2834-2840, 2003.

24)—Richard Gordon, John Karavitis, Jonas Moses, Klara Valyi-Nagy, and Andrew Maniotis. Differentiation waves versus positional information of morphogen gradients: which is cause and effect? Information Processing in Cells and Tissues, Morphomechanics of the Embryo and Genome, Lausanne , Switzerland , 2003.

25)— Robert Folberg, Jacob Pe’er, Andrew J. Maniotis. Extravascular Matrix Patterns in Uveal Melanoma: Histogenesis, Structure, and Molecular Regulation. In: Uveal Melanoma: A model for Exploring Fundamental Cancer Biology. Swets & Zeitlinger, Publishers, 2004.

26)—Eleni Papadopulos-Eleopulos, Valendar F Turner, John Papadimitriou, Barry Page, David Causer, Helman Alfonso, Sam Mhlongo, Todd Miller, Andrew Maniotis, Christian Fiala. A critique of the Montagnier evidence for the HIV/AIDS hypothesis. Med Hypotheses. 63(4):597-601, 2004.

27)—Folberg R, Maniotis A. Vasculogenic mimicry. Acta Pathologica Microbiologica et Immunologica Scandinavica, 112:508-25, 2004.

28)—Maniotis AJ, Valyi-Nagy K, Karavitis J, Moses J, Boddipali V, Wang Y, Nuñez R, Setty S, Arbieva Z, Bissell MJ, and Folberg R: Chromatin organization measured by Alu I restriction enzyme changes with malignancy and is regulated by the extracellular matrix and the cytoskeleton. Am J Pathol 166: No. 4 April 2005.

29)—Lin AY, Maniotis AJ, Valyi-Nagy K, Majumdar D, Setty S, Kadkol S, Leach L, Pe’er J, Folberg R.Distinguishing fibrovascular septa from vasculogenic mimicry patterns. Arch Pathol Lab Med. Jul;129(7):884-92, 2005.

30)—Kadkol SS, Lin AY, Barak V, Kalickman I, Leach L, Valyi-Nagy K, Majumdar D, Setty S, Maniotis AJ, Folberg R, Pe’er J. Osteopontin expression and serum levels in metastatic uveal melanoma: a pilot study. Invest Ophthalmol Vis Sci. Mar;47(3):802-6, 2006.

31)—Maniotis Andrew, Maniotis Rita, Joseph Espat N. Joseph; Chen Xue, Lycos Peter. Why is the Hepatitis B vaccine still mandated? Medical Veritas, Nov; 3(2):1206-1210, 2006.

32)— Folberg R, Arbieva Z, Moses J, Hayee A, Sandal T, Kadkol S, Lin AY, Valyi-Nagy K, Setty S, Leach L, Chevez-Barrios P, Larsen P, Majumdar D, Pe’er J, Maniotis AJ.
Tumor cell plasticity in uveal melanoma: microenvironment directed dampening of the invasive and metastatic genotype and phenotype accompanies the generation of vasculogenic mimicry patterns. Am J Pathol. Oct;169(4):1376-89, 2006.

33)—Tone Sandal, Klara Valyi-Nagy, Robert Folberg, Mina Bissell, Virginia Spensor, Andrew Maniotis. Epigenetic reversion of breast carcinoma phenotype and DNA sequestration. American Journal Of Pathology, Vol. 170(5):1739-49. May, 2007.

34)—Klara Valyi-Nagy, Robert Folberg, Tibor Valyi-Nagy, Andrew J. Maniotis. Susceptibility of Herpes simplex Virus Type I and II, The Role of Tumor Invasiveness, The Extracellular Matrix, and Chromatin Sequestration. In press, May, Experimental Eye Research, Vol. 84, 9991-10,000, 2007.

35)— Lin AY, Ai Z, Lee SC, Bajcsy P, Pe’er J, Leach L, Maniotis AJ, Folberg R. Comparing vasculogenic mimicry with endothelial cell-lined vessels: techniques for 3D reconstruction and quantitative analysis of tissue components from archival paraffin blocks. Appl Immunohistochem Mol Morphol. Mar;15(1):113-9, 2007.

36)—Folberg R, Leach L, Valyi-Nagy K, Lin AY, Apushkin MA, Ai Z, Barak V, Majumdar D, Pe’er J, Maniotis AJ. Modeling the behavior of uveal melanoma in the liver. Invest Ophthalmol Vis Sci. 2007 Jul;48(7):2967-74.

37)—. Barak V, Frenkel S, Kalickman I, Maniotis AJ, Folberg R, Pe’er J. Serum markers to detect metastatic uveal melanoma. Anticancer Res. Jul-Aug;27(4A):1897-900, 2007.

38)— Barak V., Frenkel S., Valyi-Nagy K., Leach L., Apushkin MA., Lin A., Kalickman I., Baumann N., Pe’er J., Maniotis A., Folberg R. Using the direct-injection model of early uveal melanoma hepatic metastasis to identify TPS as a clinically useful serum biomarker. Invest Ophthalmol Vis Sci. Oct;48(10):4399-402, 2007.

39)—Papadopulos-Eleopulos E, Page BA, Causer D, Turner VF, Papadimitriou JM, Maniotis A.Cancer and epigenetic reversion the fundamental role of redox. Am J Pathol. Nov;171(5):1726-7, 2007.

40)—Grace Guzman, Scott J. Cotler, Amy Y. Lin, Robert Folberg, Andrew J. Maniotis. Expression of vasculogenic mimicry correlates with earlier hepatocellular carcinoma recurrence after orthotopic liver transplant. Archives Lab. Medicine, Vol. 131, p 56-61, 2007.

–Tone Sandal, Klara Valyi-Nagy, Amin Hayee, Laurence J Marton, and Andrew J Maniotis. Sensitivity of metastatic cells to polyamine analogs is accompanied by DNA sequestration and is dependent upon cellular phenotype. Submitted.

–Andrew Maniotis, Lynn Margulis. From genophores to chromosomes, submitted.

–Lynn Margulis, Andrew Maniotis, James MacAllister, John Scythes, John Hall . Resurgence of “The Great Imitator”? Submitted.

On-line publications:

Doctors for Disaster Preparedness. Vaccines and Epidemics. How to Predict Epidemics.
http://www.ddponline.org/vande.htm

A Brief History of AIDS: http://barnesworld.blogs.com/barnes_world/2006/12/a_brief_history.html

A Global Strategy Against “AIDS” Demands Evidence Not Emotion:http://barnesworld.blogs.com/barnes_world/2007/01/a_global_strate.html

The 48 diseases that are AIDS: http://64.233.167.104/search?q=cache:eLxwWOuthgIJ:barnesworld.blogs.com/48AIDS.pdf+maniotis&hl=en&ct=clnk&cd=23&gl=us

Some expert critiques of primary work:

Work on cancer:

—Science, September 3rd, 1999. “New type of blood vessel found in tumors.” p1475.

—The Lancet, Sept. 13, 1999. “Tumors find another way to feed themselves.” p2.

—Amer. J. Path., September, 1999, “Tumor plasticity allows vasculogenic mimicry, a novel form of angiogenic switch.” pps. 675-679.

—Focus, Number 38, 20 September, 1999 . Nahung fur den Krebs. Cover story.

—Chicago Tribune, September 17, 1999. “Cancer Theory is Questioned.” Front page.

—College of American Pathologists, 2000. “Eyeing a new path for tumor growth.” Feature story.

—New Scientist: 11 Sept, 1999 . “Organized Killers,” p11.

—Science, Vol. 287, 4 Feb. 2000. “Face-off over tumor blood supply,” pps. 783-4.

—Nature Medicine, Volume 6 Number 4 April 2000. “Mechanisms of angiogenesis and arteriogenesis”, p. 392.

—The Lancet Oncology Vol 3 January 2002. Melanoma–stroma interactions: structural and functional aspects. p35-43.

—Basic Pathology, W B Saunders Co. Current 2004 Edition. In: Neoplasia; “Vasculogenic mimicry in Uveal melanomas.” V Kumar, R S Cotran and S L Robbins. Am J Pathol. 2005

—Apr;166(4):959-62. Review. Mechanogenomic control of DNA exposure and sequestration. Stein GS.

—DNA ‘Packaging’ Linked with Cancer; National Review of Medicine (Canada). ” MAY 15, 2005, VOLUME 2 NO. 9. “Protein markers flag cancer cells that are impervious to chemo.”

—Canadian Online Pharmacy Journal: Genomic DNA provides clues to new advances in cancer diagnostics Medical Research News 22-Mar-2005.

—Epigenetic reversion of breast cancer DNA.

http://www.eurekalert.org/pub_releases/2007-04/ajop-bcm042607.php

-Work on cytoskeletal mechanics, tensegrity, and genomics:

—Science ,Vol 276, 1997, pp 678-679; “Force-Carrying Web Pervades Living Cell.”.

—Annu. Rev. of Physiol., 1997 Vol. 59: 575-99. “Tensegrity: The Architectural Basis of Cellular Signal Transduction.”

—Scientific American,. January, 1998, pp48-57, “The Architecure of Life.”

—Biochem. Cell Biol., 79: 267–274 (2001). “The integration of tissue structure and nuclear function.”

-Work on centrosomes and cellular microsurgury:

—Nature, Vol 355, 1992, pp300-301. “Centrosome and Cell Division.”

—Current Opinions in Cell Biology, Vol 2, Number 5, 1992, pp.243-245. “Double or Nothing.”

Inventions
Inventions:

1. Title: Chromosome stability assay
United States Patent 20050079516 (http://www.freepatentsonline.com/20050079516.html)
Abstract:
Embodiments of the invention relate to compositions and methods for evaluating or estimating the invasive potential of cells and thereby differentiating between normal and cancerous cells in accordance with the susceptibility of the cellular chromatin to degradation or other modification by particular enzymes or agents. Chromatin within permeabilized normal and non-invasive cells, including chromatin strands removed there from, are more susceptible to degradation by endonucleases or proteinases than is the chromatin from invasive cells.

2 .Title: Methods and compositions related to a matrix chip
United States Patent Application No.425/MUMNP/2006 (http://www.tmpsearchers.com/Patdatabase/2007April20/pg_0116.htm)

Abstract:
Embodiments of the invention relate to devices and methods for evaluating the interactions between cells and between cells and matrix materials wherein the cellular distribution pattems formed as a result of such interactions are indicators of the invasive potential(s) of the cells. Furthermore, such devices and methods can provide indications of the preferred sites of metastasis of invasive cells; the efficacy of an anti-cancer drug applied to such cells; and the potential for agents to promote or enhance tumor growth or metastasis.

3. Title: Constricting gel assay and therapeutic patch
International Application No. PCT/US2006/013672
(http://www.wipo.int/pctdb/en/wo.jsp?wo=2006110827)
Abstract: Method and compositions relate diagnostic tools to determine invasive potential of tumor cells. Therapeutic patches include a component from the extracellular matrix seeded with tumor cells from an individual and a fibrin backing. Extracellular matrix-based constriction assays are useful to screen for anti-tumor compounds.

4. Title: Methods for determining the pathogenicity of viral strains
Application No. PCT/US2006.035258
(http://www.wipo.int/pctdb/en/wo.jsp?wo=2007030815)
Abstract
Methods and compositions are provided for rapidly detecting the presence and lytic potential of a pathogenic virus in a sample and for determining the pathogenicity of a viral strain to cells, as compared to merely detecting the presence of viruses in a sample. Assays determine the pathogenicity of viral strains based on the viral strains’ ability to expose nuclease sites on the host cell’s nuclear DNA (e.g. condensed chromatin in malignant cells (to a DNA nuclease).

Teaching Experience
Teaching Experience:

Spring, 1983. Instructor: “Osteology”. Department of Anthropology, Washington University, St. Louis, MO.

Fall, 1986, Spring, 1987. Instructor: “Biology 1A, 1B”. Department of Zoology, University of California, Berkeley, CA.

Fall, 1988, Lecturer: “Cytogenetics” 110, Department of Zoology, University of California , Berkeley CA .

Spring, 1989.Lecturer: “Cytogenetics Laboratory”. Department of Zoology, University of California , Berkeley CA .

Fall, 1989. Instructor, “Molecular Cell Biology”. Department of Molecular Biology, University of California , Berkeley CA .

Spring, 1990. Course Coordinator and Instructor: “Molecular Cell Biology 130” . Department of Molecular Cell Biology, University of California , Berkeley , CA .

May, 1991. Instructor: “Advanced Quantitative Light Microscopy”. Woods Hole, MA.

Fall 1997-8. Research Scientist. “Cell Biology”, graduate course. Department of Biochemistry. University of Iowa Medical College, Iowa City , IA.

Fall 2000. Assistant Professor of Pathology. Bioengineering 1A. Department of Bioengineering, University of Illinois, Chicago, Chicago, IL.

Spring, 2000. Assistant Professor of Pathology. “Cell Biology”. Department of Physiology and Biophysics. University of Illinois, Chicago, Chicago, IL.

Fall 2001. Assistant Professor of Pathology. “Pathology for 2 nd Year Medical students”. Department of Pathology. University of Illinois , Chicago, Chicago IL .

Fall 2001. Assistant Professor of Pathology. “Graduate Course in Microbiology”. Department of Microbiology. University of Illinois, Chicago, Chicago, IL.

Spring, 2002. Assistant Professor of Pathology. “Cell Biology”. Department of Physiology and Biophysics. University of Illinois, Chicago, Chicago, IL.

Fall, 2002. Assistant Professor of Pathology. “Pathology for 2 nd Year Medical Students. Department of Pathology, University of Illinois, Chicago, IL.

Spring, 2003. Assistant Professor of Pathology. “Cell Biology”. Department of Physiology and Biophysics. University of Illinois, Chicago, Chicago, IL.

Fall, 2004. Assistant Professor of Bioengineering. Senior Design Course. Department of Bioengineering, University of Illinois , Chicago, Chicago IL .

Spring, 2004. Assistant Professor of Bioengineering. Senior Design Course. Department of Bioengineering, University of Illinois , Chicago, Chicago IL .

Graduate or post-graduate level students at UIC:

* 2001-2003-Viveka Boddipalli. Developed a project in my lab at UIC involving differential chromatin stability assays. Currently, Mr. Boddipalli has been admitted into the CDC’s program of Public Health.

* 2001-2003. Ms. Ding Wu. Developed a project to quantify gel contraction weights of malignant versus non-malignant tumor cells in my lab at UIC. Currently she is at The University of Chicago obtaining a PhD.

* 2001-2003. Mr. John Karavitis, Developed a chromatin isolation assay in my lab at UIC. Currently he has completed course work toward his Ph.D. at Harvard, and has returned to Chicago to complete his PhD at Loyola Medical School.

* 2001-2002. Mr. Christopher Garcia. Graduated while in my lab. Developed a project to obtain cells lacking nuclei to access howthey could construct simple tissues in the absence of transcription. Currently, he is working for Charles Rivers as a biological model provider.

* 2002-2003, 2006. Mr. Jonas Moses. Developed an extracellular matrix assay (“bio-chip”). Currently he is leading the project on discovering mechanisms and therapeutic limitations for the use of polyamines in cancer and has completed his doctorate in the lab. Currently, he is doing a post-doctoral fellowship at Argon National Laboratories in Chicago.

* 2005. Amin Hayee. Developing a new extracellular matrix model f tumor invasion and dormancy. Currently, he is in the residency program at UIC.

MarcGirard-123x163
Tetyana Obukhanych, Ph.D.

Tetyana Obukhanych earned her Ph.D. in Immunology at the Rockefeller University in New York, NY with her research dissertation focused on understanding immunologic memory, perceived by the mainstream biomedical establishment to be key to immunity and vaccine protection. She was subsequently involved in laboratory research as a postdoctoral research fellow within leading biomedical institutions, such as Harvard Medical School and Stanford University School of Medicine.
read more

Having had several childhood diseases despite being properly vaccinated against them, Dr. Obukhanych has undertaken a thorough investigation of scientific findings regarding vaccination and immunity. Based on her analysis, Dr. Obukhanych has articulated a view that challenges mainstream assumptions and theories on vaccination in her e-book Vaccine Illusion.

Dr. Obukhanych continues her independent in-depth analysis of peer-reviewed scientific findings related to vaccination and natural requirements of the immune system function. Her goal is to bring a scientifically-substantiated and dogma-free perspective on vaccination and natural immunity to parents and health care practitioners via writing, lectures, and private consultations.

Alan.Phillips-123x163
Alan Phillips JD

Attorney Specializing in Vaccine Exemption and Waiver Law

Alan Phillips, J.D. of Chapel Hill, NC is one of the nation’s few attorneys practicing vaccine exemption and waiver law. He is published internationally on vaccine health and legal matters; an Advisory Board Member of the American Chiropractic Autism Board and a board member of the World Association for Vaccine Education; a member of the Legal Group with PandemicFluOnline.org, and co-founder of NC’s Citizens for Healthcare Freedom.
read more

Alan has appeared on radio and television shows in the US and Canada, and presented at regional and international conferences. His clients have included lay people and attorneys from around the country concerning exemptions for schools and colleges (public and private), the military (members, families, civilian contractors), immigrants (including foreign adoption), healthcare employees, homeschoolers, and parents involved in vaccine custody disputes. His e-book, “The Authoritative Guide to Vaccine Legal Exemptions” may be the only publication that provides authoritative, accurate, and detailed information about how state and federal constitutions, statutes, regulations, legal precedent, and individual facts and circumstances combine to form the precise boundaries of an individual’s right to refuse vaccines. His Vaccine Rights website is the only site on the Internet devoted exclusively to vaccine exemptions and waivers.

Alan’s “Dispelling Vaccination Myths” article was published around the world and translated into Russian, Chinese, and several European languages. It has been used in medical school classrooms in 3 different countries, and appears on websites around the world and in publications ranging from an Australian grassroots newsletter to Indian homeopathic journals and the Hindustan Times to European magazines. Recent articles on vaccine legal issues have appeared in the Townsend Letter, The American Chiropractor, and the NC Chiropractic Association’s HealthTrek Magazine.

Alan is also an accomplished singer-songwriter on piano and 12-string acoustic guitar, having received standing ovations for performances at seven international conferences and with tape sales internationally.

dan.schultz-123x163
Dan Schultz DC
Dr. Schultz began his research endeavors and efforts in 1994 as an integral part of the effort to defeat Michigan House bill 4392 that sought to eliminate personal exemptions. “I was astounded to realize what went into vaccines (ingredients) and what the actual short and long term consequences could be. Even more alarming was that very few people had taken the time or had an opportunity to educate themselves about these facts.” “I felt compelled as a citizen and free-thinking lover of truth to share what I had learned. Knowledge is certainly power. I want to empower people to make healthier, educated decisions for themselves and their children.”
EileenNicoleSimon-123x163
Eileen Nicole SimonPhD, RN
Distant past:

  • Long-time computer programmer (Smithsonian Astrophysical Observatory, American Science and Engineering, Bolt Beranek and Newman, Digital Equipment Corporation.
  • Once part of the Ultrix (Unix) group at Digital, I opted for a severance package in 1990, believing I would easily find another job as superuser somewhere…

Decade of the brain:

  • Work in state and community psychiatric hospitals.
  • MEDITECH clinical health care software.
  • Bridgewater State Hospital, 1991-present.
ken-stoller-123x163
Kenneth Stoller MD

Dr. Kenneth Stoller completed his training from the University of California at Los Angeles School of Medicine in 1986 and was a practicing pediatrician for over two decades focusing on brain injured children and adults. Dr. Stoller’s area of expertise is functional medicine, also known as integrative medicine. He has been working with patients with brain injuries ranging from traumatic brain injury, stroke, autism, cerebral palsy, MS, chemo-brain, and Lyme brain since the late 1990s.
read more

Dr. Stoller is one of the few physicians that has been made a lifetime Fellow of the American College of Hyperbaric Medicine, and he has published numerous articles on using hyperbaric oxygen to treat brain injuries. He pioneered the use of hyperbaric oxygen for treating fetal alcohol syndrome and the journal, Pediatrics published his work in 2005. Dr. Stoller is at the leading edge of physicians who use natural supplements and bio-identical hormones to help patients heal their brains.

Dr. Stoller is Board Certified in Hyperbaric Medicine and has been president of the International Hyperbaric Medical Association since 2002. He is an Adjunct Assistant Professor at the AT Still School of Medicine Arizona. He is currently our Chief of Hyperbaric Medicine and an accomplished integrative physician. Dr. Stoller specializes in Hyperbaric medicine, traumatic brain injury (TBI).

Dr. Stoller’s extracurricular activities include being the founding board member of the Humane Farming Association.

sherri-tenpenny-123x163
Sherri Tenpenny DO

Dr. Sherri J. Tenpenny is the director and founder of OsteoMed II, a clinic established in 1996 to provide the best of integrative medicine for patients in the Cleveland, Ohio area.

A graduate of the University of Toledo in Toledo, Ohio, Dr. Tenpenny received her medical training at Kirksville College of Osteopathic Medicine in Kirksville, Missouri. She is board certified in emergency medicine and osteopathic manipulative medicine. A regular guest on national radio and TV, and at medical conventions, she has published numerous articles for national magazines and medical Internet sites. She is the author of books, DVDs and educational products.
read more

Dr. Tenpenny is respected as one of the country’s most knowledgeable and outspoken physicians regarding the impact of vaccines on health. Through her education company, NMA Media Press, LLC, she spreads her vision of retaining freedom of choice in healthcare, including the freedom to refuse vaccination.
mary-tocco-123x163
Mary Tocco

Independent Vaccine Researcher, National Public Speaker

Mary is an international speaker and vaccine educator, empowering people to make informed vaccine decisions. She is the host of, Healing Our World, internet and satellite radio program, every Saturday 4:00-5:00 (EST) Republic Broadcasting Network. Since 1994, Mary is the Director of Vaccine Research and Education for Michigan Opposing Mandatory Vaccines, a watch-dog group responsible for maintaining the philosophical exemption in Michigan. She is also on the board of the World Association of Vaccine Information (W.A.V.E.) a scientific website dedicated to honest vaccine information – http://www.novaccine.com . Mary is co-founder and board member of Heart For Autism, a charitable 501C3, dedicated to raising funds for families who are working to recover their children from autism. In 2006, she produced educational vaccine DVD called, “Are Vaccines Safe?” that has been viewed by over 250,000 people world-wide – www.VaccineDVD.com . She has done extensive research into the role vaccines play in our autism crisis.